Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Apr;35(4):750-2.
doi: 10.1128/AAC.35.4.750.

Loracarbef versus cefaclor in the treatment of urinary tract infections in women

A Iravani  1
Affiliations
Clinical Trial

Loracarbef versus cefaclor in the treatment of urinary tract infections in women

A Iravani. Antimicrob Agents Chemother. 1991 Apr.

Abstract

In a double-blind, prospective, randomized study, 108 college women with acute urinary tract infections were treated for 7 days with either loracarbef (LY163892) at 200 mg once daily (n = 53) or cefaclor at 250 mg three times daily (n = 55). The cure rates at 5 to 9 days after treatment in the loracarbef and cefaclor groups were 96 and 90%, respectively. Both loracarbef and cefaclor are safe, well tolerated, and effective in the treatment of urinary tract infections in women.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Antimicrob Agents Chemother. 1982 Oct;22(4):672-7 - PubMed
    1. Antimicrob Agents Chemother. 1981 May;19(5):842-50 - PubMed
    1. Am J Med. 1988 Sep 16;85(3A):17-23 - PubMed
    1. Antimicrob Agents Chemother. 1988 Nov;32(11):1738-9 - PubMed
    1. Bacteriol Rev. 1977 Sep;41(3):667-710 - PubMed

Publication types

MeSH terms